Loading: 100%
ILLUMINA INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter San Diego, United States of AmericaSan Diego, United States of Americano data available
Employees 5,500 (as per Q2 2017)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker ILMNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17120150180210240
datesClosing price (adj.)
13.10.2017206.92
11.10.2017206.69
04.10.2017205.77
27.09.2017197.76
20.09.2017203.09
13.09.2017213.43
06.09.2017207.42
30.08.2017199.74
23.08.2017193.62
16.08.2017194.15
09.08.2017199.23
02.08.2017197.85
26.07.2017176.30
19.07.2017173.88
12.07.2017173.23
05.07.2017174.35
27.06.2017176.36
20.06.2017175.30
13.06.2017173.46
06.06.2017179.45
30.05.2017173.58
23.05.2017174.72
16.05.2017178.24
09.05.2017183.59
02.05.2017186.71
25.04.2017181.50
18.04.2017175.29
11.04.2017175.01
04.04.2017169.92
28.03.2017170.81
21.03.2017163.50
14.03.2017164.83
07.03.2017165.58
28.02.2017167.40
21.02.2017162.15
14.02.2017164.46
07.02.2017162.85
31.01.2017160.10
24.01.2017160.48
17.01.2017160.47
10.01.2017165.04
03.01.2017131.13
27.12.2016128.94
19.12.2016129.65
12.12.2016124.00
05.12.2016127.92
28.11.2016136.18
21.11.2016137.55
14.11.2016136.38
07.11.2016137.08
31.10.2016136.14
24.10.2016142.27
17.10.2016141.23
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
206.92n/a
Market Capitalisation
in million USD
30,210n/a
Enterprise Value
in million USD
29,571n/a
Common Shares Outstanding
as per Jul 28, 2017
146,000,000n/a
Preferred Shares Outstanding
as per Jul 28, 2017
n/a
Average Basic Shares Outstanding
TTM
146,377,000n/a
Average Diluted Shares Outstanding
TTM
147,478,500n/a
Index Membership
n/a
Business Summary
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 2,487n/a
Gross Profit 1,647n/a
Operating Income 500n/a
EBITDA 650n/a
Net Profit 748n/a
Balance Sheet
Cash and Cash Equivalents 1,893n/a
Receivables 372n/a
Total Current Assets 2,643n/a
PP&E 837n/a
Total Assets 4,858n/a
Accounts Payable 175n/a
Current Debt 5n/a
Total Current Liabilities 682n/a
Long-Term Debt 1,169n/a
Total Liabilities 2,063n/a
Total Equity 2,795n/a
Cash Flow
Depreciation & Amortisation 150n/a
Change in Working Capital 65n/a
Operating Cash Flow 692n/a
Net Change in PP&E and Intangibles -302n/a
Investing Cash Flow -317n/a
Dividends Paid 0n/a
Financing Cash Flow -107n/a
Total Change in Cash 267n/a
Free Cash Flow 171n/a
Profitability Ratios
Gross Margin 66.2%n/a
Operating Margin 20.1%n/a
Net Profit Margin 27.8%n/a
Return on Equity 24.8%n/a
Return on Assets 14.2%n/a
Per Share Figures
Basic EPS 5.11n/a
Diluted EPS 5.07n/a
Sales per Share 16.99n/a
Book Value per Share 18.55n/a
FCF per Share 1.17n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 40.51n/a
Price to Sales Ratio 12.18n/a
Price to Book Value 10.84n/a
Price to Free Cash Flow 176.65n/a
Valuation Metrics
EV/EBITDA 45.50n/a
EV/Sales 11.89n/a
Book to Market Value 0.09n/a
Other Ratios
Current Ratio 387.5%n/a
Liabilities to Equity Ratio 73.8%n/a
Debt to Assets Ratio 24.2%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
573
666
903
1,056
1,149
1,421
1,861
2,220
2,398
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-220
-212
-301
-346
-375
-509
-564
-670
-732
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
353
454
602
709
774
912
1,298
1,549
1,666
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-248
-317
-398
-459
-517
-658
-854
-926
-1,087
Selling, General & Administrative
-148
-176
-220
-262
-286
-381
-466
-525
-583
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-100
-141
-178
-197
-231
-277
-388
-402
-504
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
105
137
203
250
257
254
443
623
579
Non-Operating Income (Loss)
-8
-11
-16
-66
-24
-36
-70
-45
-26
Interest Expense, net
-10
-13
-16
-28
-22
-35
-38
-37
-23
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
2
1
0
-39
-2
-1
-33
-8
-2
Pretax Income (Loss), Adjusted
97
125
187
184
232
218
373
578
553
Abnormal Gains (Losses)
-25
-11
-2
-51
-10
-59
76
5
8
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
73
114
185
133
223
159
449
583
561
Income Tax (Expense) Benefit, net
-33
-42
-60
-46
-71
-34
-95
-126
-133
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
39
72
125
87
151
125
353
457
428
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
39
72
125
87
151
125
353
457
428
Minority Interest
0
0
0
0
0
0
0
4
35
Net Income
39
72
125
87
151
125
353
462
463
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
39
72
125
87
151
125
353
462
463
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 18, 2014 n/a
calculated values,
restated on Feb 18, 2015 n/a
calculated values,
restated on Mar 2, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
694
894
1,190
1,350
1,166
1,338
1,386
1,559
Cash & Cash Equivalents
n/a
145
249
303
434
712
636
769
735
Short Term Investments
n/a
549
645
887
916
454
702
617
824
Accounts & Notes Receivable
n/a
158
166
174
215
239
289
386
381
Accounts Receivable, Net
n/a
158
166
174
215
239
289
386
381
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
93
142
129
159
154
191
271
300
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
38
56
52
63
59
71
54
78
Prepaid Expenses
n/a
18
37
29
33
23
30
54
78
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
20
19
23
30
36
41
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
982
1,258
1,545
1,787
1,618
1,890
2,097
2,318
Property, Plant & Equipment, Net
n/a
117
130
143
166
203
265
343
713
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
331
451
508
613
1,199
1,185
1,248
1,250
Intangible Assets
n/a
44
91
106
130
331
315
274
243
Goodwill
n/a
213
278
322
369
723
725
753
776
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
47
39
20
40
88
50
135
123
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
27
42
60
73
56
96
87
108
Total Noncurrent Assets
n/a
448
581
651
779
1,401
1,450
1,591
1,963
Total Assets
n/a
1,430
1,839
2,196
2,566
3,019
3,340
3,688
4,281
Liabilities and owners' equity
Payables & Accruals
n/a
151 151034000
223 222908000
227 226921000
268 267604000
293 292775000
418 417902000
526 526070000
480 480000000
Accounts Payable
n/a
53 52781000
67 66744000
50 49806000
66 65727000
74 73655000
83 82626000
139 139226000
138 138000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
98 98253000
156 156164000
177 177115000
202 201877000
219 219120000
335 335276000
387 386844000
342 342000000
Short Term Debt
n/a
290 290202000
312 311609000
0 0
37 36967000
29 29288000
304 304256000
75 74929000
2 2000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
9 9495000
223 223000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
9 9495000
223 223000000
Total Current Liabilities
n/a
441 441236000
535 534517000
227 226921000
305 304571000
322 322063000
722 722158000
610 610494000
705 705000000
Long Term Debt
n/a
0 0
0 0
807 807369000
805 805406000
839 839305000
987 986780000
1,016 1015649000
1,056 1056000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
124 124453000
107 106921000
86 86335000
138 137527000
324 324154000
168 167904000
181 180505000
206 206000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
124 124453000
107 106921000
86 86335000
138 137527000
324 324154000
168 167904000
181 180505000
206 206000000
Total Noncurrent Liabilities
n/a
124 124453000
107 106921000
894 893704000
943 942933000
1,163 1163459000
1,155 1154684000
1,196 1196154000
1,262 1262000000
Total Liabilities
n/a
566 565689000
641 641438000
1,121 1120625000
1,248 1247504000
1,486 1485522000
1,877 1876842000
1,807 1806648000
1,967 1967000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
1,639 1639187000
1,893 1892804000
2,252 2251568000
2,422 2421534000
2,564 2564458000
2,175 2174745000
2,499 2499360000
2,735 2735000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-498 -497543000
-542 -541559000
-1,110 -1109763000
-1,188 -1187623000
-1,240 -1240345000
-1,272 -1272073000
-1,674 -1673608000
-2,022 -2022000000
Retained Earnings
n/a
-280 -280226000
-155 -155335000
-69 -68707000
83 82547000
208 207855000
561 561206000
1,023 1022765000
1,485 1485000000
Other Equity
n/a
3 2830000
2 1765000
2 2117000
2 2123000
1 1234000
-1 -1080000
0 36000
-1 -1000000
Equity Before Minority Interest
n/a
864 864248000
1,198 1197675000
1,075 1075215000
1,319 1318581000
1,533 1533202000
1,463 1462798000
1,849 1848553000
2,197 2197000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 282000
0 0
33 32546000
117 117000000
Total Equity
n/a
864 864248000
1,198 1197675000
1,075 1075215000
1,319 1318581000
1,533 1533484000
1,463 1462798000
1,881 1881099000
2,314 2314000000
Total Liabilities & Equity
n/a
1,430 1429937000
1,839 1839113000
2,196 2195840000
2,566 2566085000
3,019 3019006000
3,340 3339640000
3,688 3687747000
4,281 4281000000
Remarks restated on n/a restated on Feb 28, 2011 n/a restated on Feb 24, 2012 n/a restated on Feb 15, 2013 n/a restated on Feb 18, 2014 n/a restated on Feb 18, 2015 n/a restated on Mar 2, 2016 n/a restated on Feb 14, 2017 n/a restated on Aug 3, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
39
72
125
87
151
125
353
457
428
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
28
31
42
69
65
98
113
126
141
Non-Cash Items
55
81
108
167
93
10
92
114
163
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-34
-13
-2
35
-18
153
-56
-38
-45
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
88
172
273
358
292
386
501
660
687
Change in Fixed Assets & Intangibles
-96
-56
-56
-80
-81
-91
-142
-143
-271
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-157
-180
-158
-249
-27
449
-249
80
-211
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-25
-1
-98
-58
-83
-524
-3
-37
-18
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
-19
27
-14
41
96
-12
-6
-14
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-277
-257
-285
-401
-150
-70
-407
-106
-515
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
-10
0
554
0
-11
-142
-245
-61
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-26
-136
58
-508
-28
44
-141
-202
-195
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
364
47
58
52
17
-72
116
29
51
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
338
-99
116
97
-11
-39
-167
-419
-205
Net Cash Before Disc. Operations and FX
148
-183
104
54
131
278
-72
135
-32
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
148
-183
104
54
131
278
-72
135
-32
Effect of Foreign Exchange Rates
4
1
0
0
0
0
-3
-2
-2
Net Changes in Cash
152
-182
104
54
131
278
-75
133
-34
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 18, 2014 n/a
calculated values,
restated on Feb 18, 2015 n/a
calculated values,
restated on Mar 2, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo